Karl-Matthias Deppermann

Effect of preoperative chemoradiation in addition to preoperative chemotherapy: a randomised trial in stage III non-small-cell lung cancer

Michael Thomas, Christian Rübe, Petra Hoffknecht et al. · The Lancet Oncology · 2008 · 346 citations

Medicine, Oncology, Surgery +16

Five day moxifloxacin therapy compared with 7 day clarithromycin therapy for the treatment of acute exacerbations of chronic bronchitis

Robert J. Wilson, R Kubin, Ian Ballin et al. · Journal of Antimicrobial Chemotherapy · 1999 · 167 citations

Medicine, Pharmacology, Pharmacotherapy +12

Randomized Phase III Trial of Paclitaxel, Etoposide, and Carboplatin Versus Carboplatin, Etoposide, and Vincristine in Patients With Small-Cell Lung Cancer

Martin Reck, Joachim von Pawel, Hans-Nicolas Macha et al. · JNCI Journal of the National Cancer Institute · 2003 · 97 citations

Medicine, Oncology, Pharmacology +14

Efficient palliation in patients with small-cell lung cancer by a combination of paclitaxel, etoposide and carboplatin: Quality of life and 6-years’-follow-up results from a randomised phase III trial

Martin Reck, Joachim von Pawel, Hans-Nicholas Macha et al. · Lung Cancer · 2006 · 26 citations

Medicine, Oncology, Pharmacology +17

An Open-Label, Multicenter, Randomized, Phase II Study of Cisplatin and Pemetrexed With or Without Cixutumumab (IMC-A12) as a First-Line Therapy in Patients With Advanced Nonsquamous Non–Small Cell Lung Cancer

Silvia Novello, Giorgio V. Scagliotti, Gilberto de Castro et al. · Journal of Thoracic Oncology · 2016 · 21 citations · Full text

Medicine, Oncology, Pharmacotherapy +16